Suzhou UIGreen Micro&Nano Technologies (688661.SH) has resubmitted the application for an H-share issuance and listing on the Hong Kong Stock Exchange and published the application materials.
Hu Lin Micronano (688661.SH) announced that the company is applying for the overseas issuance of shares (H shares) and listing on the main board of the Hong Kong Stock Exchange. According to the schedule of this issuance, the company has resubmitted the application for issuance to the Hong Kong Stock Exchange on April 2, 2026, and published the application materials on the Hong Kong Stock Exchange website on the same day. The application materials are prepared and published by the company in accordance with the requirements of the Hong Kong Securities and Futures Commission and the Hong Kong Stock Exchange, and are in draft form. The information contained in the materials may be updated and changed in a timely manner.
Suzhou UIGreen Micro&Nano Technologies (688661.SH) announced that the company is in the process of applying for the overseas issuance of shares (H shares) and listing on the main board of the Hong Kong Stock Exchange. According to the schedule of this issuance, the company re-submitted the application to the Hong Kong Stock Exchange on April 2, 2026, and published the application documents on the Hong Kong Stock Exchange website on the same day. The application documents were prepared and published by the company in accordance with the requirements of the Securities and Futures Commission of Hong Kong and the Hong Kong Stock Exchange, and are draft versions, with the information contained possibly being updated and revised in a timely manner.
Related Articles
Medicalsystem Biotechnology (300439.SZ) obtained a medical device registration certificate.
Teyi Pharmaceutical Group (002728.SZ): Glucosamine sulfate capsules have obtained a drug registration certificate.
Zhuhai Rundu Pharmaceutical (002923.SZ): The hydrochloride of meperidine injection obtained the drug registration certificate.
Medicalsystem Biotechnology (300439.SZ) obtained a medical device registration certificate.
Teyi Pharmaceutical Group (002728.SZ): Glucosamine sulfate capsules have obtained a drug registration certificate.
Zhuhai Rundu Pharmaceutical (002923.SZ): The hydrochloride of meperidine injection obtained the drug registration certificate.
RECOMMEND
Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026
Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026
Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026
